Safety

Veramyst, (fluticasone furoate) Nasal Spray

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)  

May 2015

Summary View

USE IN SPECIFIC POPULATIONS

Hepatic Impairment
  • Use VERAMYST Nasal Spray with caution in patients with moderate or severe hepatic impairment [see Clinical Pharmacology (12.3)].

 

October 2011

Summary View

WARNINGS AND PRECAUTIONS

Local Nasal Effects
  • section added

 

ADVERSE REACTIONS

Postmarketing Experience

Respiratory, Thoracic, and Mediastinal Disorders

  • add .... : Rhinalgia, nasal discomfort (including nasal burning, nasal irritation, and nasal soreness), nasal dryness, and nasal septal perforation

 

PATIENT COUNSELING INFORMATION

Keep Spray Out of Eyes
  • section added
Potential Drug Interactions
  • section added

 

Page Last Updated: 06/12/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.